JPTCCM
SRPT icon

J.P. Turner & Co Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$241K Sell
7,500
-700
-9% -$23.8K 0.25% 136
2015
Q2 		$248K Sell
8,200
-5,700
-41% -$117K 0.19% 173
2015
Q1 		$186K Buy
13,900
+2,250
+19% +$30K 0.17% 169
2014
Q4 		$165K Buy
+11,650
New +$197K 0.16% 172

Other funds holding SRPT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

J.P. Turner & Co Capital Management's SRPT Position: Q3 2015 in Review

J.P. Turner & Co Capital Management reduced its Sarepta Therapeutics (SRPT) stake by 8.5% in Q3 2015, selling an estimated $23.8K and leaving 7,500 shares worth $241K. The position accounts for 0.25% of the portfolio, ranked #136.

J.P. Turner & Co Capital Management first reported a position in SRPT in Q4 2014 and has held it in 4 quarters since. The position peaked at $248K in Q2 2015. 149 funds tracked by Wall St. Rank hold SRPT as of Q3 2015.

  • J.P. Turner & Co Capital Management held 7,500 shares of Sarepta Therapeutics worth $241K as of Q3 2015.
  • J.P. Turner & Co Capital Management sold 700 Sarepta Therapeutics shares in Q3 2015, an estimated $23.8K.
  • Sarepta Therapeutics made up 0.25% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #136 holding.
  • J.P. Turner & Co Capital Management first reported a position in Sarepta Therapeutics in Q4 2014 and has held it in 4 quarters since.
  • J.P. Turner & Co Capital Management's Sarepta Therapeutics position peaked at $248K in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.